Literature DB >> 10857553

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.

H M Khandwala1, I E McCutcheon, A Flyvbjerg, K E Friend.   

Abstract

Several decades of basic and clinical research have demonstrated that there is an association between the insulin-like growth factors (IGFs) and neoplasia. We begin with a brief discussion of the function and regulation of expression of the IGFs, their receptors and the IGF-binding proteins (IGFBPs). A number of investigational interventional strategies targeting the GH or IGFs are then reviewed. Finally, we have assembled the available scientific knowledge about this relationship for each of the major tumor types. The tumors have been grouped together by organ system and for each of the major tumors, various key elements of the relationship between IGFs and tumor growth are discussed. Specifically these include the presence or absence of autocrine IGF-I and IGF-II production; presence or absence of IGF-I and IGF-II receptor expression; the expression and functions of the IGFBPs; in vitro and in vivo experiments involving therapeutic interventions; and available results from clinical trials evaluating the effect of GH/IGF axis down-regulation in various malignancies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857553     DOI: 10.1210/edrv.21.3.0399

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  207 in total

1.  Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.

Authors:  Danielle B Ulanet; Dale L Ludwig; C Ronald Kahn; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  The association between change in body mass index and upper aerodigestive tract cancers in the ARCAGE project: multicenter case-control study.

Authors:  Sungshim Lani Park; Yuan-Chin Amy Lee; Manuela Marron; Antonio Agudo; Wolfgang Ahrens; Luigi Barzan; Vladimir Bencko; Simone Benhamou; Christine Bouchardy; Cristina Canova; Xavier Castellsague; David I Conway; Claire M Healy; Ivana Holcátová; Kristina Kjaerheim; Pagona Lagiou; Raymond J Lowry; Tatiana V Macfarlane; Gary J Macfarlane; Bernard E McCartan; Patricia A McKinney; Franco Merletti; Hermann Pohlabeln; Lorenzo Richiardi; Lorenzo Simonato; Linda Sneddon; Renato Talamini; Dimitrios Trichopoulos; Ariana Znaor; Paul Brennan; Mia Hashibe
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

Review 3.  Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis.

Authors:  Christina M Nagle; Catherine M Olsen; Torukiri I Ibiebele; Amanda B Spurdle; Penelope M Webb
Journal:  Eur J Nutr       Date:  2012-05-22       Impact factor: 5.614

4.  The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.

Authors:  W Zesławski; H G Beisel; M Kamionka; W Kalus; R A Engh; R Huber; K Lang; T A Holak
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

Review 5.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 6.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

7.  Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro.

Authors:  P Del Monte; C Laurino; M Arvigo; C Palermo; F Minuto; A Barreca
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

8.  Variants in the GH-IGF axis confer susceptibility to lung cancer.

Authors:  Matthew F Rudd; Emily L Webb; Athena Matakidou; Gabrielle S Sellick; Richard D Williams; Helen Bridle; Tim Eisen; Richard S Houlston
Journal:  Genome Res       Date:  2006-06       Impact factor: 9.043

9.  Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.

Authors:  Charles S Fuchs; Richard M Goldberg; Daniel J Sargent; Jeffrey A Meyerhardt; Brian M Wolpin; Erin M Green; Henry C Pitot; Michael Pollak
Journal:  Clin Cancer Res       Date:  2008-12-10       Impact factor: 12.531

10.  Genetic variation in insulin-like growth factors and brain tumor risk.

Authors:  Stefan Lönn; Nathaniel Rothman; William R Shapiro; Howard A Fine; Robert G Selker; Peter M Black; Jay S Loeffler; Amy A Hutchinson; Peter D Inskip
Journal:  Neuro Oncol       Date:  2008-06-18       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.